Clinical experience with infliximab biosimilar in psoriasis

被引：11

作者：

Ricceri, F. ^{[1
]}

Pescitelli, L. ^{[1
]}

Lazzeri, L. ^{[1
]}

Prignano, F. ^{[1
]}

机构：

[1] Univ Florence, Dept Surg & Translat Med, Dermatol Unit, Viale Michelangiolo 41, I-50125 Florence, Italy

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2017年 / 177卷 / 06期

关键词：

INNOVATOR INFLIXIMAB; PARALLEL-GROUP; DOUBLE-BLIND; EFFICACY; SAFETY; CT-P13;

D O I：

10.1111/bjd.15755

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E347 / E348

页数：2

共 7 条

[1]

European Medicines Agency, 2013, ASS REP REMS INFL

[2] Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--a multinational cross-sectional study [J].

Nast, A. ;

Mrowietz, U. ;

Kragballe, K. ;

de Jong, E. M. G. J. ;

Puig, L. ;

Reich, K. ;

Warren, R. B. ;

Werner, R. ;

Kopkow, C. ;

Schmitt, J. .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2013, 305 (10) :899-907

[3] A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study [J].

Park, Won ;

Hrycaj, Pawel ;

Jeka, Slawomir ;

Kovalenko, Volodymyr ;

Lysenko, Grygorii ;

Miranda, Pedro ;

Mikazane, Helena ;

Gutierrez-Urena, Sergio ;

Lim, MieJin ;

Lee, Yeon-Ah ;

Lee, Sang Joon ;

Kim, HoUng ;

Yoo, Dae Hyun ;

Braun, Juergen .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (10) :1605-1612

[4] First experience with therapy of severe forms of psoriasis with biosimilar infliximab [J].

Tichy, M. ;

Kopova, R. ;

Sternbersky, J. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (03) :491-493

[5] Biosimilars: the science of extrapolation [J].

Weise, Martina ;

Kurki, Pekka ;

Wolff-Holz, Elena ;

Bielsky, Marie-Christine ;

Schneider, Christian K. .

BLOOD, 2014, 124 (22) :3191-3196

[6]

World Health Organization, 2009, Expert Committee on Biological Standardization: guidelines on evaluation of similar biotherapeutic products (SBPs)

[7] A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study [J].

Yoo, Dae Hyun ;

Hrycaj, Pawel ;

Miranda, Pedro ;

Ramiterre, Edgar ;

Piotrowski, Mariusz ;

Shevchuk, Sergii ;

Kovalenko, Volodymyr ;

Prodanovic, Nenad ;

Abello-Banfi, Mauricio ;

Gutierrez-Urena, Sergio ;

Morales-Olazabal, Luis ;

Tee, Michael ;

Jimenez, Renato ;

Zamani, Omid ;

Lee, Sang Joon ;

Kim, HoUng ;

Park, Won ;

Mueller-Ladner, Ulf .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (10) :1613-1620

← 1 →